nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—SLC6A4—Alzheimer's disease	0.251	0.587	CbGaD
Vilazodone—CYP2D6—Alzheimer's disease	0.176	0.413	CbGaD
Vilazodone—DRD2—Memantine—Alzheimer's disease	0.133	0.336	CbGbCtD
Vilazodone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0692	0.175	CbGbCtD
Vilazodone—CYP2D6—Donepezil—Alzheimer's disease	0.0553	0.14	CbGbCtD
Vilazodone—CYP3A4—Rivastigmine—Alzheimer's disease	0.044	0.111	CbGbCtD
Vilazodone—CYP2D6—Galantamine—Alzheimer's disease	0.0357	0.0903	CbGbCtD
Vilazodone—CYP3A4—Donepezil—Alzheimer's disease	0.0352	0.0891	CbGbCtD
Vilazodone—CYP3A4—Galantamine—Alzheimer's disease	0.0227	0.0574	CbGbCtD
Vilazodone—Suicide—Galantamine—Alzheimer's disease	0.00318	0.0265	CcSEcCtD
Vilazodone—Suicide attempt—Galantamine—Alzheimer's disease	0.00291	0.0242	CcSEcCtD
Vilazodone—Completed suicide—Galantamine—Alzheimer's disease	0.00281	0.0234	CcSEcCtD
Vilazodone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00277	0.18	CbGeAlD
Vilazodone—DRD2—telencephalic ventricle—Alzheimer's disease	0.0025	0.163	CbGeAlD
Vilazodone—Night sweats—Donepezil—Alzheimer's disease	0.00237	0.0197	CcSEcCtD
Vilazodone—Suicidal ideation—Galantamine—Alzheimer's disease	0.00235	0.0196	CcSEcCtD
Vilazodone—Suicide—Memantine—Alzheimer's disease	0.00224	0.0186	CcSEcCtD
Vilazodone—Suicide attempt—Memantine—Alzheimer's disease	0.00205	0.017	CcSEcCtD
Vilazodone—Suicide attempt—Rivastigmine—Alzheimer's disease	0.002	0.0167	CcSEcCtD
Vilazodone—Completed suicide—Memantine—Alzheimer's disease	0.00197	0.0164	CcSEcCtD
Vilazodone—Cataract—Galantamine—Alzheimer's disease	0.00173	0.0144	CcSEcCtD
Vilazodone—Suicidal ideation—Memantine—Alzheimer's disease	0.00166	0.0138	CcSEcCtD
Vilazodone—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00162	0.0135	CcSEcCtD
Vilazodone—Mania—Memantine—Alzheimer's disease	0.0016	0.0133	CcSEcCtD
Vilazodone—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.00142	0.0118	CcSEcCtD
Vilazodone—Gastroenteritis—Galantamine—Alzheimer's disease	0.00135	0.0113	CcSEcCtD
Vilazodone—Cataract—Donepezil—Alzheimer's disease	0.00134	0.0112	CcSEcCtD
Vilazodone—Abnormal dreams—Donepezil—Alzheimer's disease	0.00126	0.0105	CcSEcCtD
Vilazodone—Cataract—Memantine—Alzheimer's disease	0.00122	0.0102	CcSEcCtD
Vilazodone—Cataract—Rivastigmine—Alzheimer's disease	0.00119	0.00993	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00119	0.00989	CcSEcCtD
Vilazodone—Dry eye—Donepezil—Alzheimer's disease	0.00118	0.00983	CcSEcCtD
Vilazodone—Aripiprazole—HTR6—Alzheimer's disease	0.00108	0.346	CrCbGaD
Vilazodone—Gastroenteritis—Donepezil—Alzheimer's disease	0.00105	0.00872	CcSEcCtD
Vilazodone—Libido decreased—Donepezil—Alzheimer's disease	0.001	0.00833	CcSEcCtD
Vilazodone—Increased appetite—Donepezil—Alzheimer's disease	0.000988	0.00823	CcSEcCtD
Vilazodone—Pollakiuria—Galantamine—Alzheimer's disease	0.000956	0.00796	CcSEcCtD
Vilazodone—Gastroenteritis—Memantine—Alzheimer's disease	0.000951	0.00792	CcSEcCtD
Vilazodone—Hyponatraemia—Donepezil—Alzheimer's disease	0.000932	0.00776	CcSEcCtD
Vilazodone—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00093	0.00775	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000921	0.00767	CcSEcCtD
Vilazodone—Libido decreased—Memantine—Alzheimer's disease	0.000909	0.00757	CcSEcCtD
Vilazodone—Increased appetite—Memantine—Alzheimer's disease	0.000897	0.00747	CcSEcCtD
Vilazodone—Libido decreased—Rivastigmine—Alzheimer's disease	0.000889	0.0074	CcSEcCtD
Vilazodone—Irritability—Donepezil—Alzheimer's disease	0.000886	0.00738	CcSEcCtD
Vilazodone—Increased appetite—Rivastigmine—Alzheimer's disease	0.000877	0.00731	CcSEcCtD
Vilazodone—Hyponatraemia—Memantine—Alzheimer's disease	0.000846	0.00705	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000836	0.00696	CcSEcCtD
Vilazodone—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000828	0.00689	CcSEcCtD
Vilazodone—Hallucination—Galantamine—Alzheimer's disease	0.000824	0.00686	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000818	0.00681	CcSEcCtD
Vilazodone—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000814	0.00678	CcSEcCtD
Vilazodone—SLC6A4—forebrain—Alzheimer's disease	0.000814	0.0529	CbGeAlD
Vilazodone—Migraine—Rivastigmine—Alzheimer's disease	0.000811	0.00676	CcSEcCtD
Vilazodone—Irritability—Memantine—Alzheimer's disease	0.000804	0.0067	CcSEcCtD
Vilazodone—Eye disorder—Galantamine—Alzheimer's disease	0.000774	0.00645	CcSEcCtD
Vilazodone—Cardiac disorder—Galantamine—Alzheimer's disease	0.000769	0.0064	CcSEcCtD
Vilazodone—SLC6A4—telencephalon—Alzheimer's disease	0.000748	0.0487	CbGeAlD
Vilazodone—Breast disorder—Rivastigmine—Alzheimer's disease	0.000745	0.0062	CcSEcCtD
Vilazodone—Pollakiuria—Donepezil—Alzheimer's disease	0.000741	0.00617	CcSEcCtD
Vilazodone—Mental disorder—Galantamine—Alzheimer's disease	0.000726	0.00604	CcSEcCtD
Vilazodone—HTR1A—forebrain—Alzheimer's disease	0.000723	0.047	CbGeAlD
Vilazodone—Malnutrition—Galantamine—Alzheimer's disease	0.000721	0.00601	CcSEcCtD
Vilazodone—Flatulence—Galantamine—Alzheimer's disease	0.000711	0.00592	CcSEcCtD
Vilazodone—Dysgeusia—Galantamine—Alzheimer's disease	0.000706	0.00588	CcSEcCtD
Vilazodone—Nervousness—Galantamine—Alzheimer's disease	0.0007	0.00583	CcSEcCtD
Vilazodone—Vision blurred—Galantamine—Alzheimer's disease	0.00068	0.00566	CcSEcCtD
Vilazodone—Tremor—Galantamine—Alzheimer's disease	0.000676	0.00563	CcSEcCtD
Vilazodone—Pollakiuria—Memantine—Alzheimer's disease	0.000673	0.0056	CcSEcCtD
Vilazodone—Erectile dysfunction—Memantine—Alzheimer's disease	0.000671	0.00559	CcSEcCtD
Vilazodone—HTR1A—telencephalon—Alzheimer's disease	0.000665	0.0432	CbGeAlD
Vilazodone—Agitation—Galantamine—Alzheimer's disease	0.000663	0.00552	CcSEcCtD
Vilazodone—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000658	0.00548	CcSEcCtD
Vilazodone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000656	0.00546	CcSEcCtD
Vilazodone—DRD2—forebrain—Alzheimer's disease	0.000653	0.0425	CbGeAlD
Vilazodone—Hallucination—Donepezil—Alzheimer's disease	0.000639	0.00532	CcSEcCtD
Vilazodone—Palpitations—Galantamine—Alzheimer's disease	0.000637	0.00531	CcSEcCtD
Vilazodone—Convulsion—Galantamine—Alzheimer's disease	0.000625	0.0052	CcSEcCtD
Vilazodone—Arthralgia—Galantamine—Alzheimer's disease	0.000614	0.00511	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00061	0.00508	CcSEcCtD
Vilazodone—Dry mouth—Galantamine—Alzheimer's disease	0.0006	0.005	CcSEcCtD
Vilazodone—DRD2—telencephalon—Alzheimer's disease	0.0006	0.0391	CbGeAlD
Vilazodone—Hallucination—Memantine—Alzheimer's disease	0.00058	0.00483	CcSEcCtD
Vilazodone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000577	0.00481	CcSEcCtD
Vilazodone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000573	0.00477	CcSEcCtD
Vilazodone—Skin disorder—Galantamine—Alzheimer's disease	0.000572	0.00476	CcSEcCtD
Vilazodone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000569	0.00474	CcSEcCtD
Vilazodone—Hallucination—Rivastigmine—Alzheimer's disease	0.000567	0.00473	CcSEcCtD
Vilazodone—Mental disorder—Donepezil—Alzheimer's disease	0.000562	0.00468	CcSEcCtD
Vilazodone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00056	0.00467	CcSEcCtD
Vilazodone—Malnutrition—Donepezil—Alzheimer's disease	0.000559	0.00465	CcSEcCtD
Vilazodone—Flatulence—Donepezil—Alzheimer's disease	0.000551	0.00459	CcSEcCtD
Vilazodone—Dysgeusia—Donepezil—Alzheimer's disease	0.000547	0.00456	CcSEcCtD
Vilazodone—Eye disorder—Memantine—Alzheimer's disease	0.000545	0.00454	CcSEcCtD
Vilazodone—Nervousness—Donepezil—Alzheimer's disease	0.000543	0.00452	CcSEcCtD
Vilazodone—Cardiac disorder—Memantine—Alzheimer's disease	0.000541	0.00451	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000536	0.00447	CcSEcCtD
Vilazodone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000533	0.00444	CcSEcCtD
Vilazodone—Insomnia—Galantamine—Alzheimer's disease	0.000532	0.00443	CcSEcCtD
Vilazodone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000529	0.00441	CcSEcCtD
Vilazodone—Paraesthesia—Galantamine—Alzheimer's disease	0.000529	0.0044	CcSEcCtD
Vilazodone—Vision blurred—Donepezil—Alzheimer's disease	0.000527	0.00439	CcSEcCtD
Vilazodone—Tremor—Donepezil—Alzheimer's disease	0.000524	0.00436	CcSEcCtD
Vilazodone—Somnolence—Galantamine—Alzheimer's disease	0.000523	0.00436	CcSEcCtD
Vilazodone—Dyspepsia—Galantamine—Alzheimer's disease	0.000518	0.00431	CcSEcCtD
Vilazodone—Agitation—Donepezil—Alzheimer's disease	0.000514	0.00428	CcSEcCtD
Vilazodone—Decreased appetite—Galantamine—Alzheimer's disease	0.000512	0.00426	CcSEcCtD
Vilazodone—Mental disorder—Memantine—Alzheimer's disease	0.000511	0.00425	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000508	0.00423	CcSEcCtD
Vilazodone—Malnutrition—Memantine—Alzheimer's disease	0.000507	0.00423	CcSEcCtD
Vilazodone—Fatigue—Galantamine—Alzheimer's disease	0.000507	0.00423	CcSEcCtD
Vilazodone—Flatulence—Memantine—Alzheimer's disease	0.0005	0.00416	CcSEcCtD
Vilazodone—Mental disorder—Rivastigmine—Alzheimer's disease	0.0005	0.00416	CcSEcCtD
Vilazodone—Dysgeusia—Memantine—Alzheimer's disease	0.000497	0.00414	CcSEcCtD
Vilazodone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000496	0.00413	CcSEcCtD
Vilazodone—Nervousness—Memantine—Alzheimer's disease	0.000493	0.0041	CcSEcCtD
Vilazodone—Flatulence—Rivastigmine—Alzheimer's disease	0.000489	0.00407	CcSEcCtD
Vilazodone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000486	0.00405	CcSEcCtD
Vilazodone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000485	0.00404	CcSEcCtD
Vilazodone—Convulsion—Donepezil—Alzheimer's disease	0.000484	0.00403	CcSEcCtD
Vilazodone—Nervousness—Rivastigmine—Alzheimer's disease	0.000482	0.00402	CcSEcCtD
Vilazodone—Vision blurred—Memantine—Alzheimer's disease	0.000478	0.00398	CcSEcCtD
Vilazodone—Arthralgia—Donepezil—Alzheimer's disease	0.000476	0.00396	CcSEcCtD
Vilazodone—Tremor—Memantine—Alzheimer's disease	0.000475	0.00396	CcSEcCtD
Vilazodone—Vision blurred—Rivastigmine—Alzheimer's disease	0.000468	0.0039	CcSEcCtD
Vilazodone—Agitation—Memantine—Alzheimer's disease	0.000466	0.00388	CcSEcCtD
Vilazodone—Dry mouth—Donepezil—Alzheimer's disease	0.000465	0.00388	CcSEcCtD
Vilazodone—Tremor—Rivastigmine—Alzheimer's disease	0.000465	0.00387	CcSEcCtD
Vilazodone—Agitation—Rivastigmine—Alzheimer's disease	0.000456	0.0038	CcSEcCtD
Vilazodone—Palpitations—Memantine—Alzheimer's disease	0.000448	0.00373	CcSEcCtD
Vilazodone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000447	0.00373	CcSEcCtD
Vilazodone—SLC6A4—nervous system—Alzheimer's disease	0.000442	0.0287	CbGeAlD
Vilazodone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000441	0.00367	CcSEcCtD
Vilazodone—Convulsion—Memantine—Alzheimer's disease	0.00044	0.00366	CcSEcCtD
Vilazodone—Palpitations—Rivastigmine—Alzheimer's disease	0.000439	0.00365	CcSEcCtD
Vilazodone—Arthralgia—Memantine—Alzheimer's disease	0.000432	0.0036	CcSEcCtD
Vilazodone—Convulsion—Rivastigmine—Alzheimer's disease	0.00043	0.00358	CcSEcCtD
Vilazodone—SLC6A4—central nervous system—Alzheimer's disease	0.000425	0.0277	CbGeAlD
Vilazodone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000423	0.00352	CcSEcCtD
Vilazodone—Dry mouth—Memantine—Alzheimer's disease	0.000423	0.00352	CcSEcCtD
Vilazodone—Asthenia—Galantamine—Alzheimer's disease	0.000422	0.00352	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00042	0.0035	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000416	0.00346	CcSEcCtD
Vilazodone—Aripiprazole—SLC6A4—Alzheimer's disease	0.000414	0.133	CrCbGaD
Vilazodone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000413	0.00344	CcSEcCtD
Vilazodone—Insomnia—Donepezil—Alzheimer's disease	0.000413	0.00344	CcSEcCtD
Vilazodone—Trazodone—SLC6A4—Alzheimer's disease	0.000412	0.132	CrCbGaD
Vilazodone—Paraesthesia—Donepezil—Alzheimer's disease	0.00041	0.00341	CcSEcCtD
Vilazodone—Nervous system disorder—Memantine—Alzheimer's disease	0.000406	0.00338	CcSEcCtD
Vilazodone—Somnolence—Donepezil—Alzheimer's disease	0.000406	0.00338	CcSEcCtD
Vilazodone—Diarrhoea—Galantamine—Alzheimer's disease	0.000403	0.00335	CcSEcCtD
Vilazodone—Skin disorder—Memantine—Alzheimer's disease	0.000402	0.00335	CcSEcCtD
Vilazodone—Dyspepsia—Donepezil—Alzheimer's disease	0.000402	0.00334	CcSEcCtD
Vilazodone—Hyperhidrosis—Memantine—Alzheimer's disease	0.0004	0.00333	CcSEcCtD
Vilazodone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000397	0.00331	CcSEcCtD
Vilazodone—Decreased appetite—Donepezil—Alzheimer's disease	0.000397	0.0033	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000394	0.00328	CcSEcCtD
Vilazodone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000394	0.00328	CcSEcCtD
Vilazodone—Fatigue—Donepezil—Alzheimer's disease	0.000393	0.00327	CcSEcCtD
Vilazodone—CYP2D6—forebrain—Alzheimer's disease	0.000392	0.0255	CbGeAlD
Vilazodone—HTR1A—nervous system—Alzheimer's disease	0.000392	0.0255	CbGeAlD
Vilazodone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000392	0.00326	CcSEcCtD
Vilazodone—Dizziness—Galantamine—Alzheimer's disease	0.000389	0.00324	CcSEcCtD
Vilazodone—HTR1A—central nervous system—Alzheimer's disease	0.000378	0.0246	CbGeAlD
Vilazodone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000377	0.00314	CcSEcCtD
Vilazodone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000376	0.00313	CcSEcCtD
Vilazodone—Insomnia—Memantine—Alzheimer's disease	0.000375	0.00312	CcSEcCtD
Vilazodone—Vomiting—Galantamine—Alzheimer's disease	0.000374	0.00312	CcSEcCtD
Vilazodone—Paraesthesia—Memantine—Alzheimer's disease	0.000372	0.0031	CcSEcCtD
Vilazodone—HTR1A—cerebellum—Alzheimer's disease	0.000369	0.024	CbGeAlD
Vilazodone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000369	0.00307	CcSEcCtD
Vilazodone—Somnolence—Memantine—Alzheimer's disease	0.000368	0.00307	CcSEcCtD
Vilazodone—Insomnia—Rivastigmine—Alzheimer's disease	0.000366	0.00305	CcSEcCtD
Vilazodone—Dyspepsia—Memantine—Alzheimer's disease	0.000365	0.00304	CcSEcCtD
Vilazodone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000364	0.00303	CcSEcCtD
Vilazodone—CYP2D6—telencephalon—Alzheimer's disease	0.000361	0.0235	CbGeAlD
Vilazodone—Somnolence—Rivastigmine—Alzheimer's disease	0.00036	0.003	CcSEcCtD
Vilazodone—Decreased appetite—Memantine—Alzheimer's disease	0.00036	0.003	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000358	0.00298	CcSEcCtD
Vilazodone—Fatigue—Memantine—Alzheimer's disease	0.000357	0.00297	CcSEcCtD
Vilazodone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000357	0.00297	CcSEcCtD
Vilazodone—DRD2—nervous system—Alzheimer's disease	0.000354	0.0231	CbGeAlD
Vilazodone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000352	0.00293	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00035	0.00291	CcSEcCtD
Vilazodone—Nausea—Galantamine—Alzheimer's disease	0.00035	0.00291	CcSEcCtD
Vilazodone—Fatigue—Rivastigmine—Alzheimer's disease	0.000349	0.00291	CcSEcCtD
Vilazodone—Feeling abnormal—Memantine—Alzheimer's disease	0.000341	0.00284	CcSEcCtD
Vilazodone—DRD2—central nervous system—Alzheimer's disease	0.000341	0.0222	CbGeAlD
Vilazodone—SLC6A4—brain—Alzheimer's disease	0.000338	0.022	CbGeAlD
Vilazodone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000334	0.00278	CcSEcCtD
Vilazodone—DRD2—cerebellum—Alzheimer's disease	0.000334	0.0217	CbGeAlD
Vilazodone—Asthenia—Donepezil—Alzheimer's disease	0.000327	0.00273	CcSEcCtD
Vilazodone—Aripiprazole—HTR2A—Alzheimer's disease	0.000318	0.102	CrCbGaD
Vilazodone—Trazodone—HTR2A—Alzheimer's disease	0.000317	0.101	CrCbGaD
Vilazodone—Diarrhoea—Donepezil—Alzheimer's disease	0.000312	0.0026	CcSEcCtD
Vilazodone—Dizziness—Donepezil—Alzheimer's disease	0.000302	0.00251	CcSEcCtD
Vilazodone—HTR1A—brain—Alzheimer's disease	0.0003	0.0195	CbGeAlD
Vilazodone—Asthenia—Memantine—Alzheimer's disease	0.000297	0.00247	CcSEcCtD
Vilazodone—Aripiprazole—CYP2D6—Alzheimer's disease	0.000291	0.0932	CrCbGaD
Vilazodone—Asthenia—Rivastigmine—Alzheimer's disease	0.000291	0.00242	CcSEcCtD
Vilazodone—Vomiting—Donepezil—Alzheimer's disease	0.00029	0.00242	CcSEcCtD
Vilazodone—Trazodone—CYP2D6—Alzheimer's disease	0.00029	0.0927	CrCbGaD
Vilazodone—Diarrhoea—Memantine—Alzheimer's disease	0.000283	0.00236	CcSEcCtD
Vilazodone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000277	0.00231	CcSEcCtD
Vilazodone—Dizziness—Memantine—Alzheimer's disease	0.000274	0.00228	CcSEcCtD
Vilazodone—Nausea—Donepezil—Alzheimer's disease	0.000271	0.00226	CcSEcCtD
Vilazodone—DRD2—brain—Alzheimer's disease	0.000271	0.0176	CbGeAlD
Vilazodone—Dizziness—Rivastigmine—Alzheimer's disease	0.000268	0.00223	CcSEcCtD
Vilazodone—Vomiting—Memantine—Alzheimer's disease	0.000263	0.00219	CcSEcCtD
Vilazodone—Vomiting—Rivastigmine—Alzheimer's disease	0.000258	0.00215	CcSEcCtD
Vilazodone—Nausea—Memantine—Alzheimer's disease	0.000246	0.00205	CcSEcCtD
Vilazodone—Nausea—Rivastigmine—Alzheimer's disease	0.000241	0.002	CcSEcCtD
Vilazodone—CYP3A4—nervous system—Alzheimer's disease	0.000216	0.0141	CbGeAlD
Vilazodone—CYP2D6—nervous system—Alzheimer's disease	0.000213	0.0139	CbGeAlD
Vilazodone—CYP3A4—central nervous system—Alzheimer's disease	0.000208	0.0136	CbGeAlD
Vilazodone—CYP2D6—central nervous system—Alzheimer's disease	0.000205	0.0133	CbGeAlD
Vilazodone—CYP2D6—cerebellum—Alzheimer's disease	0.0002	0.013	CbGeAlD
Vilazodone—CYP2D6—brain—Alzheimer's disease	0.000163	0.0106	CbGeAlD
Vilazodone—DRD2—GPCR downstream signaling—IAPP—Alzheimer's disease	2.25e-05	0.000578	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GAB2—Alzheimer's disease	2.25e-05	0.000577	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—SST—Alzheimer's disease	2.25e-05	0.000577	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—MAPK8—Alzheimer's disease	2.24e-05	0.000575	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PYY—Alzheimer's disease	2.23e-05	0.000573	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP2D6—Alzheimer's disease	2.22e-05	0.000571	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—HTR2A—Alzheimer's disease	2.2e-05	0.000566	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDK5—Alzheimer's disease	2.2e-05	0.000565	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—F2—Alzheimer's disease	2.2e-05	0.000565	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—APP—Alzheimer's disease	2.19e-05	0.000563	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CRH—Alzheimer's disease	2.18e-05	0.000561	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.18e-05	0.000561	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—NPS—Alzheimer's disease	2.14e-05	0.00055	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.13e-05	0.000547	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR6—Alzheimer's disease	2.12e-05	0.000544	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—BCHE—Alzheimer's disease	2.11e-05	0.000541	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—NPS—Alzheimer's disease	2.07e-05	0.000531	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.07e-05	0.000531	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—NPY—Alzheimer's disease	2.06e-05	0.000528	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.05e-05	0.000527	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IAPP—Alzheimer's disease	2.04e-05	0.000524	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GAB2—Alzheimer's disease	2.04e-05	0.000524	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—SST—Alzheimer's disease	2.04e-05	0.000524	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2e-05	0.000513	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—APP—Alzheimer's disease	1.99e-05	0.000511	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PLCB1—Alzheimer's disease	1.99e-05	0.000511	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CRH—Alzheimer's disease	1.98e-05	0.000509	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GAB2—Alzheimer's disease	1.98e-05	0.000507	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—SST—Alzheimer's disease	1.98e-05	0.000507	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CCL2—Alzheimer's disease	1.96e-05	0.000504	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.95e-05	0.0005	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDK5—Alzheimer's disease	1.93e-05	0.000496	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—F2—Alzheimer's disease	1.93e-05	0.000496	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ABCA1—Alzheimer's disease	1.93e-05	0.000495	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PSENEN—Alzheimer's disease	1.93e-05	0.000494	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—APP—Alzheimer's disease	1.92e-05	0.000494	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APH1A—Alzheimer's disease	1.9e-05	0.000487	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—NPS—Alzheimer's disease	1.88e-05	0.000483	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PLCB1—Alzheimer's disease	1.88e-05	0.000482	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.87e-05	0.00048	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR6—Alzheimer's disease	1.86e-05	0.000478	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.86e-05	0.000477	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	1.85e-05	0.000474	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.82e-05	0.000466	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	1.8e-05	0.000463	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—SST—Alzheimer's disease	1.79e-05	0.00046	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GAB2—Alzheimer's disease	1.79e-05	0.00046	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.78e-05	0.000457	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	1.76e-05	0.000452	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	1.76e-05	0.000452	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—APP—Alzheimer's disease	1.75e-05	0.000449	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CCL2—Alzheimer's disease	1.72e-05	0.000442	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.71e-05	0.00044	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PSENEN—Alzheimer's disease	1.69e-05	0.000434	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.68e-05	0.000431	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APH1A—Alzheimer's disease	1.67e-05	0.000428	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARGC1A—Alzheimer's disease	1.66e-05	0.000427	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.65e-05	0.000425	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HMOX1—Alzheimer's disease	1.65e-05	0.000425	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PLCB1—Alzheimer's disease	1.65e-05	0.000423	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NCSTN—Alzheimer's disease	1.62e-05	0.000417	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LRP1—Alzheimer's disease	1.58e-05	0.000406	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—TP53—Alzheimer's disease	1.56e-05	0.000401	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	1.55e-05	0.000398	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAL—Alzheimer's disease	1.55e-05	0.000397	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GFAP—Alzheimer's disease	1.55e-05	0.000397	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.53e-05	0.000393	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—LPL—Alzheimer's disease	1.51e-05	0.000388	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	1.5e-05	0.000386	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.45e-05	0.000372	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—Alzheimer's disease	1.43e-05	0.000367	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.43e-05	0.000366	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.42e-05	0.000364	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.39e-05	0.000357	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	1.38e-05	0.000355	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	1.37e-05	0.000353	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—A2M—Alzheimer's disease	1.36e-05	0.00035	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—Alzheimer's disease	1.36e-05	0.00035	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.34e-05	0.000345	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.34e-05	0.000345	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	1.33e-05	0.000343	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PSEN2—Alzheimer's disease	1.32e-05	0.000339	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	1.32e-05	0.000338	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	1.29e-05	0.000331	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.27e-05	0.000327	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CALM1—Alzheimer's disease	1.27e-05	0.000327	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.27e-05	0.000327	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOE—Alzheimer's disease	1.27e-05	0.000326	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	1.27e-05	0.000325	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.26e-05	0.000323	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAV1—Alzheimer's disease	1.26e-05	0.000323	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.25e-05	0.00032	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	1.24e-05	0.000319	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	1.24e-05	0.000318	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.22e-05	0.000313	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NPY—Alzheimer's disease	1.21e-05	0.000312	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.21e-05	0.000312	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IAPP—Alzheimer's disease	1.21e-05	0.00031	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	1.21e-05	0.00031	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SST—Alzheimer's disease	1.21e-05	0.00031	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	1.21e-05	0.00031	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	1.2e-05	0.000309	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	1.2e-05	0.000307	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APP—Alzheimer's disease	1.18e-05	0.000302	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CRH—Alzheimer's disease	1.17e-05	0.000301	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.16e-05	0.000299	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCR5—Alzheimer's disease	1.16e-05	0.000297	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.13e-05	0.00029	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	1.13e-05	0.00029	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.12e-05	0.000288	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NPS—Alzheimer's disease	1.11e-05	0.000285	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	1.11e-05	0.000285	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.11e-05	0.000284	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARG—Alzheimer's disease	1.1e-05	0.000284	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—F2—Alzheimer's disease	1.09e-05	0.00028	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTK2B—Alzheimer's disease	1.09e-05	0.00028	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—INS—Alzheimer's disease	1.08e-05	0.000278	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.08e-05	0.000278	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.07e-05	0.000274	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.07e-05	0.000274	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	1.06e-05	0.000272	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SST—Alzheimer's disease	1.06e-05	0.000272	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	1.06e-05	0.000272	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	1.06e-05	0.000271	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	1.05e-05	0.00027	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	1.04e-05	0.000266	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APP—Alzheimer's disease	1.03e-05	0.000265	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	1.03e-05	0.000264	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.02e-05	0.000262	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	1.01e-05	0.00026	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	1.01e-05	0.000258	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—F2—Alzheimer's disease	9.92e-06	0.000255	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.84e-06	0.000253	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	9.74e-06	0.00025	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	9.56e-06	0.000245	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.51e-06	0.000244	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NOS3—Alzheimer's disease	9.5e-06	0.000244	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	9.11e-06	0.000234	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	9.09e-06	0.000233	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	9.03e-06	0.000232	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	8.88e-06	0.000228	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	8.84e-06	0.000227	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	8.8e-06	0.000226	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—Alzheimer's disease	8.69e-06	0.000223	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	8.44e-06	0.000217	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—S100B—Alzheimer's disease	8.4e-06	0.000216	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	8.37e-06	0.000215	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.27e-06	0.000212	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	8.21e-06	0.000211	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.17e-06	0.00021	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	7.99e-06	0.000205	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	7.99e-06	0.000205	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	7.78e-06	0.0002	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.75e-06	0.000199	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.75e-06	0.000199	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	7.73e-06	0.000198	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	7.61e-06	0.000195	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LPL—Alzheimer's disease	7.41e-06	0.00019	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	7.34e-06	0.000189	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	7.21e-06	0.000185	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.2e-06	0.000185	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	7.1e-06	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	7.08e-06	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	7.08e-06	0.000182	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGF—Alzheimer's disease	7.02e-06	0.00018	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	7.01e-06	0.00018	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.97e-06	0.000179	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.97e-06	0.000179	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	6.83e-06	0.000175	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.8e-06	0.000174	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	6.75e-06	0.000173	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.68e-06	0.000172	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	6.68e-06	0.000172	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—F2—Alzheimer's disease	6.67e-06	0.000171	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.59e-06	0.000169	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	6.53e-06	0.000168	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.43e-06	0.000165	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	6.23e-06	0.00016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.21e-06	0.00016	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—Alzheimer's disease	6.21e-06	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LEP—Alzheimer's disease	6.21e-06	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	6.15e-06	0.000158	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	6.13e-06	0.000157	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	6.08e-06	0.000156	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INS—Alzheimer's disease	6.04e-06	0.000155	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	5.95e-06	0.000153	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	5.93e-06	0.000152	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2—Alzheimer's disease	5.86e-06	0.00015	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	5.85e-06	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.73e-06	0.000147	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.68e-06	0.000146	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.65e-06	0.000145	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.41e-06	0.000139	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	5.38e-06	0.000138	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.34e-06	0.000137	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	5.34e-06	0.000137	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INS—Alzheimer's disease	5.31e-06	0.000136	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	5.3e-06	0.000136	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	5.22e-06	0.000134	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.17e-06	0.000133	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	5.13e-06	0.000132	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.07e-06	0.00013	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.07e-06	0.00013	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.97e-06	0.000128	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.71e-06	0.000121	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.65e-06	0.000119	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	4.65e-06	0.000119	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.54e-06	0.000117	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	4.5e-06	0.000116	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	4.47e-06	0.000115	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.44e-06	0.000114	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—Alzheimer's disease	4.37e-06	0.000112	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.35e-06	0.000112	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.33e-06	0.000111	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.31e-06	0.000111	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.29e-06	0.00011	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.14e-06	0.000106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.12e-06	0.000106	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.99e-06	0.000102	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	3.95e-06	0.000101	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	3.93e-06	0.000101	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.82e-06	9.8e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.77e-06	9.69e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.71e-06	9.53e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INS—Alzheimer's disease	3.7e-06	9.5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.7e-06	9.49e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	3.63e-06	9.32e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	3.62e-06	9.3e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.5e-06	9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.38e-06	8.68e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	3.35e-06	8.61e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.25e-06	8.33e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	3.08e-06	7.9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.04e-06	7.81e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.97e-06	7.62e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	2.89e-06	7.41e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.84e-06	7.3e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.83e-06	7.27e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.81e-06	7.21e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	2.64e-06	6.78e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.53e-06	6.5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.47e-06	6.33e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	2.44e-06	6.25e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INS—Alzheimer's disease	2.42e-06	6.21e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—Alzheimer's disease	2.32e-06	5.95e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	2.14e-06	5.49e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.12e-06	5.45e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.94e-06	4.98e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.49e-06	3.83e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.76e-07	2.5e-05	CbGpPWpGaD
